Table 1. Baseline characteristics
 CharacteristicsIntervention group(n = 372)Usual care group(n = 317)
 Mean age, years (SD)65.1 (8.3)66.2 (7.5)
 Age <65 years175 (47)132 (42)
 Female158 (42)132 (42)
 Western358 (96)295 (93)
Cardiovascular risk factors
 Hypertensiona 280 (75)234 (74)
 Hypercholesterolemiaa 91 (24)91 (29)
 Current smokerb 43 (12)32 (10)
 Chronic kidney diseasec 40 (11)51 (16)
 Microalbuminuriac 15 (4)10 (3)
 Rheumatoid arthritisa 4 (1)10 (3)
Cardiovascular diseasesa,d 172 (46)162 (51)
 Myocardial infarction41 (11)48 (15)
 Coronary sclerosis46 (12)44 (14)
 Angina pectoris44 (12)39 (12)
 Transient ischaemic attack33 (9)31 (10)
 Cerebral infarction35 (9)17 (5)
 Aneurysm aortae8 (2)11 (3)
 Intermittent claudication12 (3)13 (4)
 Atherosclerosis4 (1)4 (1)
Comorbidities (including other CVD)a
 COPD9 (2)14 (4)
 Atrial fibrillation23 (6)16 (5)
 Heart failure1 (0.3)3 (1)
Medication use b
 Antihypertensive agents299 (80)251 (79)
 Statins/lipid-lowering agents190 (51)167 (53)
 Anticoagulants169 (45)154 (49)
Measurementse
 Mean SBP, mmHg (SD)136.7 (15.2) —
 Mean DBP, mmHg (SD)80.3 (9.5) —
 Mean LDL-cholesterol, mmol/l (SD)2.8 (0.9) —
 Mean BMI (SD)27.7 (4.0) —
  • aBased on International Classification of Primary Care (ICPC)-coded diagnoses. bBased on medical records. cBased on ICPC-coded diagnoses and/or laboratory measurements. Microalbuminuria: albumin-creatinine ratio >3 mg/mmol. Chronic kidney disease: ≥3 months impaired renal function (estimated glomerular filtration rate <60 ml/minute/1.73 m2) and/or microalbuminuria.dCardiovascular diseases as inclusion criteria for integrated CVRM care and for the study. eBaseline measurements of the control group at t = 0 are not presented, as there was no routine intake consultation.

  • BMI = body mass index. COPD = chronic obstructive pulmonary disease. CVD = cardiovascular diseases. DBP = diastolic blood pressure. LDL = low-density lipoprotein. SBP = systolic blood pressure. SD = standard deviation.

  • Absolute numbers (%) are presented unless stated otherwise.